Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Apr 08, 2026

Schwab U.S. Dividend Equity ETF (SCHD): Key Drivers for Its Dividend Growth Outlook

Key Takeaways

  • Robust inflows exceeding $15 billion recently signal strong investor demand amid value rotation, positioning SCHD for enhanced liquidity and stability.
  • Recent 2026 index reconstitution trimmed energy exposure while boosting healthcare and technology, emphasizing higher dividend growth stocks for resilient future yields.
  • Defensive sector tilts in consumer staples and healthcare offer protection against economic slowdowns, with tailwinds from anticipated Fed rate cuts.
  • Macro sensitivity to interest rates favors SCHD's quality focus, as lower rates could steepen yield curves and support financial holdings.
  • Upcoming earnings from top holdings like Chevron (CVX) and Merck (MRK) may drive performance amid AI-related infrastructure spending in industrials.
  • Structural low expense ratio of 0.06% enhances long-term compounding in a dividend growth environment.

Understanding SCHD's Portfolio and Strategy

The Schwab U.S. Dividend Equity ETF (SCHD) tracks the Dow Jones U.S. Dividend 100 Index, which selects around 100 high-dividend-yielding U.S. companies based on consistent dividend payments and key fundamental metrics such as cash flow-to-debt and return on equity (ROE). In my view, this rules-based approach stands out because it prioritizes dividend sustainability and growth rather than chasing the highest yields alone, giving investors exposure to financially robust large-cap value stocks.

SCHD's holdings are heavily concentrated in the United States (over 95%), with sector diversification across consumer defensive (~19%), healthcare (~19%), energy (~17%), industrials (~11%), and information technology (~11%). As of early 2026, top holdings include Chevron (CVX) at 4.4%, ConocoPhillips (COP) at 4.3%, Merck (MRK) at 4.2%, Coca-Cola (KO) at 4.1%, and Texas Instruments (TXN) at 4.1%. The recent reconstitution brought in names like UnitedHealth (UNH) and Qualcomm (QCOM), which I see as adding to the ETF's quality and growth potential.

From what I see, this setup positions SCHD well for the long haul, with quality dividend payers that hold up in volatile markets, an ultra-low expense ratio of 0.06%, and assets under management over $85 billion. That combination supports tax efficiency and scalability for portfolios balancing income and moderate growth.

Catalysts I'm Watching for SCHD

Several factors could shape SCHD's path ahead. The March 2026 index reconstitution—the largest in its history—cut energy weighting by about 7-8% while lifting healthcare and tech exposure, focusing on stocks with 60%+ five-year dividend growth rates, well above those that were trimmed. This built-in "buy low, sell high" dynamic seems poised to help sustain yield growth through sector shifts.

With Federal Reserve rate cuts expected 2-3 times through 2026, we could see a steeper yield curve that benefits financials and eases borrowing costs for consumer staples and healthcare holdings. Energy prices remain unpredictable due to geopolitical tensions, which could impact leaders like CVX and COP.

Recent inflows topping $15 billion underscore demand for dividend strategies, which may bolster price stability. I also checked upcoming earnings from key holdings like pharma giants MRK and UNH, where operational efficiencies and AI-driven healthcare innovations could influence flows and rebalances.

Sector Breakdown and Broader Macro View

The Dow Jones U.S. Dividend 100 Index underpinning SCHD emphasizes quality factors, which aligns nicely with a macro backdrop of moderate U.S. GDP growth (2-2.6%) and Fed easing. Falling rates should make dividend stocks more attractive relative to bonds while supporting spending in staples like KO and PepsiCo (PEP).

Healthcare, at ~19% of the portfolio, stands to gain from tech advances and efficiencies, while energy (~17%) is linked to commodity cycles and supply risks. Consumer staples add defensiveness against lingering inflation, and new tech additions like QCOM provide AI exposure without excessive growth risks. Financials may benefit from deregulation and a steeper curve, though credit issues warrant caution. Overall, the index's strong fundamentals should offer resilience as markets rotate toward value.

Trend Prediction Engine

Tickeron’s Trend Prediction Engine is an AI-powered tool I rely on to forecast whether assets like SCHD might trend bullish, bearish, or sideways over the next week or month. It processes massive datasets to detect emerging trends, potential breakouts or reversals, and generates predictions for thousands of instruments, including major ETFs. With searchable categories, historical pattern matching, and customizable alerts for high-probability moves, it's invaluable for both short-term trading and long-term positioning amid volatility. In my analysis of SCHD, I've found it sharpens my view on ETF trends—worth exploring to bolster your own forecasts.

Long-Term Trends Supporting SCHD

This is important because SCHD's outlook ties into lasting themes like demographic pressures boosting healthcare demand and reliable consumer staples usage, reinforced by the index's dividend growth focus. Energy holdings reflect global transition trends, while industrials tap AI infrastructure and capex cycles. As economic cycles favor quality over speculation and rates normalize, SCHD's low-volatility profile should shine.

Holdings like Lockheed Martin (LMT) in defense and Home Depot (HD) in housing-related areas capture policy-backed growth. Broader shifts toward income amid aging populations further support SCHD's ~3.4% yield and compounding power, rooted in the Dow Jones U.S. Dividend 100 Index's track record.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: SCHD

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


SCHD in +0.76% Uptrend, rising for three consecutive days on August 14, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SCHD advanced for three days, in of 319 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 372 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SCHD broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are ABBVIE (NYSE:ABBV), Cisco Systems (NASDAQ:CSCO), Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Merck & Co (NYSE:MRK), Home Depot (NYSE:HD), Texas Instruments (NASDAQ:TXN), Amgen (NASDAQ:AMGN), Verizon Communications (NYSE:VZ), PepsiCo (NASDAQ:PEP).

Industry description

The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100™ Index. To pursue its goal, the fund generally invests in stocks that are included in the index. The index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. The fund will invest at least 90% of its net assets in these stocks.

Market Cap

The average market capitalization across the Schwab US Dividend Equity ETF™ ETF is 53.7B. The market cap for tickers in the group ranges from 482.12M to 468.22B. ABBV holds the highest valuation in this group at 468.22B. The lowest valued company is AMSF at 482.12M.

High and low price notable news

The average weekly price growth across all stocks in the Schwab US Dividend Equity ETF™ ETF was 12%. For the same ETF, the average monthly price growth was 36%, and the average quarterly price growth was 137%. MRK experienced the highest price growth at 12%, while SIG experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the Schwab US Dividend Equity ETF™ ETF was 16%. For the same stocks of the ETF, the average monthly volume growth was -4% and the average quarterly volume growth was -35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 35
P/E Growth Rating: 44
Price Growth Rating: 45
SMR Rating: 46
Profit Risk Rating: 55
Seasonality Score: -32 (-100 ... +100)
View a ticker or compare two or three
SCHD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category LargeValue

Profile
Details
Category
Large Value
Address
Schwab Strategic Trust101 Montgomery StreetSan Francisco
Phone
1-800-435-4000
Web
www.csimfunds.com.
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.